Welcome to Episode 6 of 6; of the 8th Annual International C. diff. Post-Conference Special series Sponsored by Summit Therapeutics. This year's Live Online Conference had robust dynamics while focusing on the leading HAI - Clostridioides difficile We will hear from the following keynote speakers:

Camilla S. Graham, MD, MPH, Ri-Co-DIFy: Summit's Ridinilazole Phase 3 Trial to Advance the Sciences in the Treatment of C. difficile and Reduction of Recurrence.

Maureen Spencer, RN, M.Ed., CIC, Engaging Middle School Children In Infection Prevention Through the C Diff Foundation's Junior Infection Fighters Program.

Alba Muhlfeld, C. diff. Survivor, Patient's Journey.

Erik Dubberke, MD, MSPH, Optimizing Prevention of Hospital-Onset

Clostridioides difficile Infection.

Many of the presentation slides are available to view/download until January 14th, 2021 located on the dedicated conference website: www.cdiff2020.com